Home Media / News Center

October-

National Liver Awareness Month

For more information visit the American Liver Foundation www.liverfoundation.org

November-

American Diabetes Month

For more information visit the American Diabetes Association www.diabetes.org

Diabetes Impact: What can be done to lessen its affect on the bottom line?

Many corporations are discovering that an
investment in their employees to encourage
overall good health, that
ultimately includes prevention and management of disease, pays dividends in the long run. more...

For the most recent changes to the NPS Formulary, click here.

The patent life of a drug is 17 years from the time the
chemical entity is identified in the lab. It can take another 10 years before the drug is tested on humans. Patent dates are continuously being updated
and changed. Listed are recent additions to the drugs coming off patent in the years 2009 and 2010.
(Current List)

H1N1

2009 H1N1 (referred to as “swine flu” early on) is a new influenza virus causing illness in humans. This new virus was first detected in people in the U.S. in April 2009. In June 2009 the World Health Organization signaled that a pandemic of 2009 H1N1 flu was underway. The level of pandemic signifies that this is a serious virus and that we all need to take precautions to protect ourselves from becoming ill. Prevention is the best way to protect yourself and your family members from becoming infected with the H1N1 virus. Practicing good hygiene and receiving a H1N1 vaccine are key steps to staying healthy this flu season. more...

Important Information on Oxycontin^®

The generic formulations of oxycodone sustained-release (OxyContin) will no longer be available. Generic formulations of oxycodone sustained-release were equally safe, effective, and held to the same quality standards as the brand-name product OxyContin. However, a successful patent challenge has forced generic oxycodone sustained-release from the market until 2013. more...

P&T Committee Actions

Our national Formulary is reviewed each quarter by a Pharmacy and Therapeutics Committee (P&T) which includes physicians and pharmacists. Our formulary applies only to outpatient prescription medications dispensed by participating pharmacies. more...

Pending Lawsuits
& Recalls

As a service to its plans, PTI tracks pending class action lawsuit settlements on behalf of our plan sponsors. With the complexities of the drug marketplace, PTI stays abreast of developments and will assist our plans in the submission and capture of settlements that may benefit their plans. Settlements are becoming more common and relate to a variety of factors and allegations of pharmaceutical manufacturers. more...

Drug Updates

The most recent drug updates released by the FDA include Botox and Botox Cosmetic and Myobloc, Ceftriaxone, CellCept - more...

The NPS Generic Incentive Program adds an additional dimension to the Therapeutic Interchange and Drug Utilization programs to increase the motivation for a member to switch to a therapeutically equivalent generic by offering an "incentive" to switch. more...